Clinical applications of gadobenate dimeglumine-enhanced magnetic resonance cholangiography: an expanded pictorial review

Gadobenate dimeglumine (Gd-BOPTA) is taken up by functioning hepatocellular cells and is partially excreted into the biliary system; therefore, it can be used as a potential intrabiliary contrast agent for magnetic resonance cholangiography applications for various clinical conditions such as obstructive disorders (e.g., choledocholithiasis, hepatolithiasis), inflammatory disorders (e.g., acute cholecystitis, cholangitis), benign biliary disorders, and pre- and postprocedural evaluation of the biliary system. In this pictorial review, we aimed to demonstrate the clinical applications of Gd-BOPTA as an intrabiliary contrast agent for imaging various biliary pathologies.